Liaw YF - Search Results

1

Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study.

Lee KC, Cheng JS, Chang ML, Chien RN, Liaw YF. Lee KC, et al. Among authors: liaw yf. Hepatol Int. 2022 Aug;16(4):799-806. doi: 10.1007/s12072-022-10357-0. Epub 2022 Jun 14. Hepatol Int. 2022. PMID: 35699864

2

Management of patients with chronic hepatitis B.

Liaw YF. Liaw YF. J Gastroenterol Hepatol. 2002 Apr;17(4):406-8. doi: 10.1046/j.1440-1746.2002.02736.x. J Gastroenterol Hepatol. 2002. PMID: 11982720 Review.

3

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF. Hsu YS, et al. Among authors: liaw yf. Hepatology. 2002 Jun;35(6):1522-7. doi: 10.1053/jhep.2002.33638. Hepatology. 2002. PMID: 12029639

4

Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: role of viral infection.

Tai DI, Chen CH, Chang TT, Chen SC, Liao LY, Kuo CH, Chen YY, Chen GH, Yang SS, Tang HS, Lin HH, Lin DY, Lo SK, Du JM, Lin KC, Changchien CS, Chang WY, Sheu JC, Liaw YF, Chen DS, Sung JL. Tai DI, et al. Among authors: liaw yf. J Gastroenterol Hepatol. 2002 Jun;17(6):682-9. doi: 10.1046/j.1440-1746.2002.02747.x. J Gastroenterol Hepatol. 2002. PMID: 12100614

5

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection.

Chen YC, Sheen IS, Chu CM, Liaw YF. Chen YC, et al. Among authors: liaw yf. Gastroenterology. 2002 Oct;123(4):1084-9. doi: 10.1053/gast.2002.36026. Gastroenterology. 2002. PMID: 12360470

6

Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B.

Liaw YF. Liaw YF. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S333-7. doi: 10.1046/j.1440-1746.17.s3.23.x. J Gastroenterol Hepatol. 2002. PMID: 12472959 Review.

7

Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications.

Tsai SL, Sheen IS, Chien RN, Chu CM, Huang HC, Chuang YL, Lee TH, Liao SK, Lin CL, Kuo GC, Liaw YF. Tsai SL, et al. Among authors: liaw yf. J Biomed Sci. 2003 Jan-Feb;10(1):120-35. doi: 10.1007/BF02256004. J Biomed Sci. 2003. PMID: 12566993

8

The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.

Chien RN, Lin CH, Liaw YF. Chien RN, et al. Among authors: liaw yf. J Hepatol. 2003 Mar;38(3):322-7. doi: 10.1016/s0168-8278(02)00419-1. J Hepatol. 2003. PMID: 12586298

9

Asian-Pacific consensus statement on the management of chronic hepatitis B: an update.

Liaw YF, Leung N, Guan R, Lau GK, Merican I; Asian-Pacific Consensus Working Parties on Hepatitis B. Liaw YF, et al. J Gastroenterol Hepatol. 2003 Mar;18(3):239-45. doi: 10.1046/j.1440-1746.2003.03037.x. J Gastroenterol Hepatol. 2003. PMID: 12603522 Review. No abstract available.

10

Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.

Liaw YF. Liaw YF. J Gastroenterol Hepatol. 2003 Mar;18(3):246-52. doi: 10.1046/j.1440-1746.2003.02976.x. J Gastroenterol Hepatol. 2003. PMID: 12603523 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

554 results

Search Page